B
Bernadette Liemberger
Researcher at Paracelsus Private Medical University of Salzburg
Publications - 12
Citations - 86
Bernadette Liemberger is an academic researcher from Paracelsus Private Medical University of Salzburg. The author has contributed to research in topics: Biology & Epidermolysis bullosa. The author has an hindex of 3, co-authored 5 publications receiving 35 citations.
Papers
More filters
Journal ArticleDOI
Predictable CRISPR/Cas9-Mediated COL7A1 Reframing for Dystrophic Epidermolysis Bullosa.
Thomas Kocher,Oliver Patrick March,Johannes Bischof,Bernadette Liemberger,Stefan Hainzl,Alfred Klausegger,Anna Hoog,Dirk Strunk,Johann W. Bauer,Ulrich Koller +9 more
TL;DR: This work demonstrates that COL7A1 editing based on precise end joining-mediated DNA repair is an efficient strategy to revert the disease-associated nature of DEB, regardless of the mutational inheritance.
Journal ArticleDOI
RNA Trans-Splicing Modulation via Antisense Molecule Interference.
Bernadette Liemberger,Josefina Piñón Hofbauer,Verena Wally,Claudia Arzt,Stefan Hainzl,Thomas Kocher,Eva M. Murauer,Johann W. Bauer,Julia Reichelt,Ulrich Koller +9 more
TL;DR: A modified, easily applicable, fluorescence-based screening system for the generation and analysis of antisense molecules specifically capable of improving the RNA reprogramming efficiency of a selected KRT14-specific RNA trans-splicing molecule is described.
Journal ArticleDOI
Generation of rabbit polyclonal human and murine collagen VII monospecific antibodies: A useful tool for dystrophic epidermolysis bullosa therapy studies.
Olivier Bornert,Thomas Kocher,Christine Gretzmeier,Bernadette Liemberger,Stefan Hainzl,Ulrich Koller,Alexander Nyström +6 more
TL;DR: Rabbit polyclonal antibodies that recognize either human or murine collagen VII are generated by immunization with homologous peptides and combined sequence alignment and peptide competition binding assays enabled identification of the major antisera recognizing epitopes.
Journal ArticleDOI
A non-viral and selection-free COL7A1 HDR approach with improved safety profile for dystrophic epidermolysis bullosa.
Thomas Kocher,Johannes Bischof,Simone A. Haas,Oliver Patrick March,Bernadette Liemberger,Stefan Hainzl,Julia Illmer,Anna Hoog,Katharina Muigg,Heide-Marie Binder,Alfred Klausegger,Dirk Strunk,Johann W. Bauer,Toni Cathomen,Ulrich Koller +14 more
TL;DR: Detailed on- and off-target analyses confirmed that the combined treatment of paired nicking and single-stranded oligonucleotides constituted a highly efficient COL7A1 editing strategy, associated with a significantly improved safety profile, and represent a further advancement in the field of traceless genome editing for genodermatoses.
Journal ArticleDOI
Personalized Development of Antisense Oligonucleotides for Exon Skipping Restores Type XVII Collagen Expression in Junctional Epidermolysis Bullosa.
Michael Ablinger,Thomas Lettner,Nicole Friedl,Hannah Potocki,Theresa Palmetzhofer,Ulrich Koller,Julia Illmer,Bernadette Liemberger,Stefan Hainzl,Alfred Klausegger,Manuela Reisenberger,Jo Lambert,Mireille Van Gele,Eline Desmet,Els Van Maelsaeke,M. Wimmer,R. Zauner,Johann W. Bauer,Verena Wally +18 more
TL;DR: In this paper, the authors designed and tested three AONs in combination with a cationic liposomal carrier for exon skipping of COL17A1 exon 7 in 2D culture and in 3D skin equivalents.